about
Nanoways to overcome docetaxel resistance in prostate cancer.Effect of engineered TiO2 and ZnO nanoparticles on erythrocytes, platelet-rich plasma and giant unilamelar phospholipid vesicles.Progesterone signaling mediated through progesterone receptor membrane component-1 in ovarian cells with special emphasis on ovarian cancerEnhanced apoptosis of ovarian cancer cells via nanocarrier-mediated codelivery of siRNA and doxorubicin.Self-assembled silk fibroin nanoparticles loaded with binary drugs in the treatment of breast carcinoma.Design and engineering of nanogels for cancer treatment.Curcumin nanoformulations: a future nanomedicine for cancer.The potentials of nanotechnology-based drug delivery system for treatment of ovarian cancer.The application of gold nanoparticles as a promising therapeutic approach in breast and ovarian cancer.Design of curcumin loaded cellulose nanoparticles for prostate cancer.Nanoceria-mediated delivery of doxorubicin enhances the anti-tumour efficiency in ovarian cancer cells via apoptosis.IBC's 21st Annual Antibody Engineering and 8th Annual Antibody Therapeutics International Conferences and 2010 Annual Meeting of the Antibody Society. December 5-9, 2010, San Diego, CA USA.
P2860
Q33909084-86928FE5-00C4-4E39-BA26-6A784B4E2999Q34545985-D0D40B60-B745-40D7-8B8D-984CBCD5D51CQ35085921-7EDC41BC-E192-4438-90D7-7A613A892075Q36148627-71B41205-211D-43B5-BF39-2EC314BA7079Q37241907-F7EA5C7D-7D62-4358-B170-71E3BE5E2E22Q37854158-91B2742F-661A-45E7-AC8F-7FC4EAC41762Q37940793-B477EA26-1CA3-4C96-90DB-17D7FF0619C5Q38163588-EA076408-86AC-40F6-8E8E-8D41B13CCD13Q38419992-A5CD8DC7-DE65-45F9-AFF7-4F26D5CF36A2Q39479428-1C36B46C-E361-48DD-83C1-56F1C952FA33Q41529535-B0629B38-082D-42DB-8738-9CF53EE8DE4EQ42732010-054DE50D-46A3-4541-BC4C-3F30567BF043
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Scope of nanotechnology in ovarian cancer therapeutics.
@ast
Scope of nanotechnology in ovarian cancer therapeutics.
@en
Scope of nanotechnology in ovarian cancer therapeutics.
@nl
type
label
Scope of nanotechnology in ovarian cancer therapeutics.
@ast
Scope of nanotechnology in ovarian cancer therapeutics.
@en
Scope of nanotechnology in ovarian cancer therapeutics.
@nl
prefLabel
Scope of nanotechnology in ovarian cancer therapeutics.
@ast
Scope of nanotechnology in ovarian cancer therapeutics.
@en
Scope of nanotechnology in ovarian cancer therapeutics.
@nl
P2093
P2860
P356
P1476
Scope of nanotechnology in ovarian cancer therapeutics.
@en
P2093
Meena Jaggi
Murali M Yallapu
Subhash C Chauhan
P2860
P2888
P356
10.1186/1757-2215-3-19
P577
2010-08-06T00:00:00Z
P5875
P6179
1012700210